HIV-1 infection abrogates CD8 +T cell mitogen-activated protein kinase signaling responses

Journal of Virology

Volumn 85, Issue 23, 2011, Pages 12343-12350

  Crawford, Timothy Q ^a   Ndhlovu, Lishomwa C ^a   Tan, Alice ^b   Carvidi, Alex ^b   Hecht, Frederick M ^b   Sinclair, Elizabeth ^b   Barbour, Jason D ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ADULT; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 81255184391     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05682-11     Document Type: Article

References (30)

1. Adler, H. S., and K. Steinbrink. 2008. MAP kinase p38 and its relation to T cell anergy and suppressor function of regulatory T cells. Cell Cycle 7:169-170.
2. Appay, V., et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-385.
3. Barbour, J. D., et al. 2009. High CD8+ T cell activation marks a less differentiated HIV-1 specific CD8+ T cell response that is not altered by suppression of viral replication. PLoS One 4:e4408.
4. Carroll, M. P., and W. S. May. 1994. Protein kinase C-mediated serine phosphorylation directly activates Raf-1 in murine hematopoietic cells. J. Biol. Chem. 269:1249-1256.
5. Champagne, P., et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-111.
6. Chatila, T., L. Silverman, R. Miller, and R. Geha. 1989. Mechanisms of T cell activation by the calcium ionophore ionomycin. J. Immunol. 143:1283-1289.
7. Chow, S., H. Patel, and D. W. Hedley. 2001. Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry 46:72-78.
8. Cuadrado, A., and A. R. Nebreda. 2010. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429:403-417.
9. Deeks, S. G., et al. 2004. Immune activation set point during early HIV infection predicts subsequent CD4+ T cell changes independent of viral load. Blood 104:942-947.
10. DeSilva, D. R., E. A. Jones, W. S. Feeser, E. J. Manos, and P. A. Scherle. 1997. The p38 mitogen-activated protein kinase pathway in activated and anergic Th1 cells. Cell Immunol. 180:116-123.
11. D'Souza, W. N., C. F. Chang, A. M. Fischer, M. Li, and S. M. Hedrick. 2008. The Erk2 MAPK regulates CD8 T cell proliferation and survival. J. Immunol. 181:7617-7629.
12. Farley, N., et al. 2006. p38 mitogen-activated protein kinase mediates the Fas-induced mitochondrial death pathway in CD8+ T cells. Mol. Cell. Biol. 26:2118-2129.
13. Fischer, A. M., C. D. Katayama, G. Pages, J. Pouyssegur, and S. M. Hedrick. 2005. The role of erk1 and erk2 in multiple stages of T cell development. Immunity 23:431-443.
14. Furler, R. L., and C. H. Uittenbogaart. 2010. Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response. Immunol. Res. 48:99-109.
15. Gorelik, G., and B. Richardson. 2010. Key role of ERK pathway signaling in lupus. Autoimmunity 43:17-22.
16. Jones, R. B., et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205:2763-2779.
17. Kothe, D., et al. 2003. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J. Acquir. Immune Defic. Syndr. 33:625-634.
18. Leng, Q., G. Borkow, and Z. Bentwich. 2002. Attenuated signaling associated with immune activation in HIV-1-infected individuals. Biochem. Biophys. Res. Commun. 298:464-467.
19. McNeil, L. K., T. K. Starr, and K. A. Hogquist. 2005. A requirement for sustained ERK signaling during thymocyte positive selection in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:13574-13579.
20. Meloche, S., and J. Pouyssegur. 2007. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26:3227-3239.
21. Northfield, J. W., et al. 2007. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point. J. Virol. 81:5759-5765.
22. Papagno, L., et al. 2004. Immune activation and CD8+ T cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2:E20.
23. + individuals. Blood 92:198-206.
24. Schweneker, M., D. Favre, J. N. Martin, S. G. Deeks, and J. M. McCune. 2008. HIV-induced changes in T cell signaling pathways. J. Immunol. 180: 6490-6500.
25. Singh, K., et al. 2009. ERK-dependent T cell receptor threshold calibration in rheumatoid arthritis. J. Immunol. 183:8258-8267.
26. Teixeiro, E., and M. A. Daniels. 2010. ERK and cell death: ERK location and T cell selection. FEBS J. 277:30-38.
27. Tomiyama, H., H. Takata, T. Matsuda, and M. Takiguchi. 2004. Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur. J. Immunol. 34:999-1010.
28. van Baarle, D., S. Kostense, M. H. van Oers, D. Hamann, and F. Miedema. 2002. Failing immune control as a result of impaired CD8+ T cell maturation: CD27 might provide a clue. Trends Immunol. 23:586-591.
29. Witte, V., et al. 2008. Induction of HIV transcription by Nef involves Lck activation and protein kinase CΘ raft recruitment leading to activation of ERK1/2 but not NFκB. J. Immunol. 181:8425-8432.
30. Zampieri, C. A., J. F. Fortin, G. P. Nolan, and G. J. Nabel. 2007. The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J. Virol. 81:1230-1240.